Miron D[au] - Search Results

Year	Number of Results
1973	1
1976	1
1984	1
1985	1
1987	3
1989	1
1990	2
1991	4
1992	2
1993	5
1994	1
1995	3
1996	2
1997	3
1998	5
1999	6
2000	7
2001	4
2002	6
2003	12
2004	6
2005	8
2006	3
2007	7
2008	4
2009	8
2010	9
2011	3
2012	11
2013	12
2014	8
2015	8
2016	12
2017	3
2018	3
2019	4
2020	4
2021	6

1

A novel extended prophylactic antibiotic regimen in preterm pre-labor rupture of membranes: A randomized trial.

Wolf MF, Sgayer I, Miron D, Krencel A, Sheffer VF, Idriss SS, Sammour RN, Peleg D, Shachar IB, Rechnitzer H, Bornstein J. Wolf MF, et al. Among authors: miron d. Int J Infect Dis. 2020 Jul;96:254-259. doi: 10.1016/j.ijid.2020.05.005. Epub 2020 May 11. Int J Infect Dis. 2020. PMID: 32407901 Free article. Clinical Trial.

2

Commonality between BCS and TCS.

Shah VP, Rădulescu FŞ, Miron DS, Yacobi A. Shah VP, et al. Among authors: miron ds. Int J Pharm. 2016 Jul 25;509(1-2):35-40. doi: 10.1016/j.ijpharm.2016.05.032. Epub 2016 May 18. Int J Pharm. 2016. PMID: 27208656 Review.

3

Risk Factors for Mortality among Newborns with Neonatal Seizures.

Tanous O, Watad M, Felszer-Fisch C, Peniakov M, Miron D, Salim R. Tanous O, et al. Among authors: miron d. Neuropediatrics. 2021 Apr;52(2):84-91. doi: 10.1055/s-0040-1712487. Epub 2020 Oct 22. Neuropediatrics. 2021. PMID: 33091941

4

Neonatal shigellosis.

Viner Y, Miron D, Gottfried E, Segal D, Luder A. Viner Y, et al. Among authors: miron d. Isr Med Assoc J. 2001 Dec;3(12):964-6. Isr Med Assoc J. 2001. PMID: 11794928 Free article. Review. No abstract available.

5

[Cryptosporidiosis].

Miron D, Kenes J. Miron D, et al. Harefuah. 1990 Feb 15;118(4):229-32. Harefuah. 1990. PMID: 2189804 Review. Hebrew. No abstract available.

6

Building and Sustaining a Culture of Innovation in an Academic Health Centre.

Merkand RR, Miron D, Peacocke S, Parker K. Merkand RR, et al. Among authors: miron d. Healthc Q. 2020 Jul;23(2):24-29. doi: 10.12927/hcq.2020.26278. Healthc Q. 2020. PMID: 32762817

7

Dissolution-bioequivalence non-correlations.

Mircioiu C, Mircioiu I, Voicu V, Miron D. Mircioiu C, et al. Among authors: miron d. Basic Clin Pharmacol Toxicol. 2005 Mar;96(3):262-4. doi: 10.1111/j.1742-7843.2005.pto960324.x. Basic Clin Pharmacol Toxicol. 2005. PMID: 15733230 Free article. No abstract available.

8

Betulinic Acid and Brosimine B Hybrid Derivatives as Potential Agents against Female Cancers.

Garcês de Couto NM, Willig JB, Ruaro TC, de Oliveira DL, Buffon A, Pilger DA, Arruda MSP, Miron D, Zimmer AR, Gnoatto SCB. Garcês de Couto NM, et al. Among authors: miron d. Anticancer Agents Med Chem. 2020;20(5):622-633. doi: 10.2174/1871520620666200124111634. Anticancer Agents Med Chem. 2020. PMID: 31976847

9

A science based approach to topical drug classification system (TCS).

Shah VP, Yacobi A, Rădulescu FŞ, Miron DS, Lane ME. Shah VP, et al. Among authors: miron ds. Int J Pharm. 2015 Aug 1;491(1-2):21-5. doi: 10.1016/j.ijpharm.2015.06.011. Epub 2015 Jun 10. Int J Pharm. 2015. PMID: 26070249 Review.

10

The forgotten or underestimated relevance of biopharmaceutical-based assessments for the oral absorption studies of oxime reactivators.

Voicu VA, Medvedovici AV, Sakurada K, Ohta H, Rădulescu FȘ, Miron DS. Voicu VA, et al. Among authors: miron ds. Expert Opin Drug Metab Toxicol. 2016 Jul;12(7):743-52. doi: 10.1080/17425255.2016.1179282. Epub 2016 May 4. Expert Opin Drug Metab Toxicol. 2016. PMID: 27144662 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results